118 related articles for article (PubMed ID: 12005158)
1. Effects of in vitro exposure of alcohol on surface receptor expression of human platelets.
McKenzie ME; Bell CR; Horowitz ED; Oshrine BR; Atar D; Serebruany VL
Clin Physiol Funct Imaging; 2002 Mar; 22(2):153-6. PubMed ID: 12005158
[TBL] [Abstract][Full Text] [Related]
2. Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets.
McKenzie ME; Malinin AI; Bell CR; Dzhanashvili A; Horowitz ED; Oshrine BR; Atar D; Serebruany VL
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):249-53. PubMed ID: 12695747
[TBL] [Abstract][Full Text] [Related]
3. Depression is associated with an increase in the expression of the platelet adhesion receptor glycoprotein Ib.
Walsh MT; Dinan TG; Condren RM; Ryan M; Kenny D
Life Sci; 2002 May; 70(26):3155-65. PubMed ID: 12008098
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa.
Schneider DJ; Taatjes DJ; Sobel BE
Cardiovasc Res; 2000 Jan; 45(2):437-46. PubMed ID: 10728364
[TBL] [Abstract][Full Text] [Related]
5. Effect of eptifibatide for acute coronary syndromes: rapid versus late administration--therapeutic yield on platelets (The EARLY Platelet Substudy).
Gurbel PA; Galbut B; Bliden KP; Bahr RD; Roe MT; Serebruany VL; Gibler WB; Christenson RH; Ohman EM;
J Thromb Thrombolysis; 2002 Dec; 14(3):213-9. PubMed ID: 12913401
[TBL] [Abstract][Full Text] [Related]
6. Surface expression of major membrane glycoproteins on resting and TRAP-activated neonatal platelets.
Simák J; Holada K; Janota J; Stranák Z
Pediatr Res; 1999 Oct; 46(4):445-9. PubMed ID: 10509366
[TBL] [Abstract][Full Text] [Related]
7. The effects of aprotonin on platelets in vitro using whole blood flow cytometry.
Kozek-Langenecker SA; Mohammad SF; Masaki T; Green W; Kamerath C; Cheung AK
Anesth Analg; 2000 Jan; 90(1):12-6. PubMed ID: 10624968
[TBL] [Abstract][Full Text] [Related]
8. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
[TBL] [Abstract][Full Text] [Related]
9. Profound inhibition of GPIb, GPIIb/IIIa, PECAM-1, CD63, and CD107 in a chronic drug addict: selecting controls for platelet flow cytometry in the inner city hospital.
Bell CR; Horowitz ED; Oshrine BR; Serebruany VL
Thromb Res; 2001 Feb; 101(3):217-8. PubMed ID: 11291427
[No Abstract] [Full Text] [Related]
10. P-selectin expression on platelets determines size and stability of platelet aggregates.
Merten M; Thiagarajan P
Circulation; 2000 Oct; 102(16):1931-6. PubMed ID: 11034941
[TBL] [Abstract][Full Text] [Related]
11. Differential in vitro effects of the platelet glycoprotein IIb/IIIa inhibitors abixicimab or SR121566A on platelet aggregation, fibrinogen binding and platelet secretory parameters.
Klinkhardt U; Kirchmaier CM; Westrup D; Breddin HK; Mahnel R; Graff J; Hild M; Harder S
Thromb Res; 2000 Feb; 97(4):201-7. PubMed ID: 10674406
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical activation of major platelet receptors in the methadone-maintained patients after single pill of aspirin.
Malinin AI; Callahan KP; Serebruany VL
Thromb Res; 2001 Nov; 104(4):297-9. PubMed ID: 11728532
[TBL] [Abstract][Full Text] [Related]
13. Disappearance of glycoprotein Ib from the platelet surface in pericardial blood during cardiopulmonary bypass.
Maquelin KN; Berckmans RJ; Nieuwland R; Schaap MC; ten Have K; Eijsman L; Sturk A
J Thorac Cardiovasc Surg; 1998 May; 115(5):1160-5. PubMed ID: 9605086
[TBL] [Abstract][Full Text] [Related]
14. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
[TBL] [Abstract][Full Text] [Related]
15. Effects of nitric oxide/EDRF on platelet surface glycoproteins.
Michelson AD; Benoit SE; Furman MI; Breckwoldt WL; Rohrer MJ; Barnard MR; Loscalzo J
Am J Physiol; 1996 May; 270(5 Pt 2):H1640-8. PubMed ID: 8928869
[TBL] [Abstract][Full Text] [Related]
16. Platelet activation in flowing blood passing growing arterial thrombi.
Hagberg IA; Roald HE; Lyberg T
Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1331-6. PubMed ID: 9261264
[TBL] [Abstract][Full Text] [Related]
17. The effects of nitric oxide (NO) on platelet membrane receptor expression during activation with human alpha-thrombin.
Keh D; Gerlach M; Kürer I; Seiler S; Kerner T; Falke KJ; Gerlach H
Blood Coagul Fibrinolysis; 1996 Sep; 7(6):615-24. PubMed ID: 8899151
[TBL] [Abstract][Full Text] [Related]
18. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists.
Michelson AD; Furman MI; Goldschmidt-Clermont P; Mascelli MA; Hendrix C; Coleman L; Hamlington J; Barnard MR; Kickler T; Christie DJ; Kundu S; Bray PF
Circulation; 2000 Mar; 101(9):1013-8. PubMed ID: 10704169
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of integrin alpha(IIb) beta(IIIa) in drug-naïve, first-episode schizophrenic patients.
Walsh MT; Ryan M; Hillmann A; Condren R; Kenny D; Dinan T; Thakore JH
Biol Psychiatry; 2002 Nov; 52(9):874-9. PubMed ID: 12399140
[TBL] [Abstract][Full Text] [Related]
20. Cardiopulmonary bypass leads to a preferential loss of activated platelets. A flow cytometric assay of platelet surface antigens.
Wahba A; Black G; Koksch M; Rothe G; Preuner J; Schmitz G; Birnbaum DE
Eur J Cardiothorac Surg; 1996; 10(9):768-73. PubMed ID: 8905280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]